Unlocking the Mysteries, Bridging the Gap, and Unveiling the Multifaceted Potential of Stem Cell Therapy for Cardiac Tissue Regeneration: A Narrative Review of Current Literature, Ethical Challenges, and Future Perspectives

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2023 Aug 8

PMID 37551212

Authors

Muhammad Abubakar

Muhammad Faiq Masood

Izzah Javed

Hira Adil

Muhammad Ahmad Faraz

Rakshita Ramesh Bhat

Mahek Fatima

Ahmad M Abdelkhalek

Barbara Buccilli

Saud Raza

Mohsin Hajjaj

Affiliations

Soon will be listed here.

Abstract

Revolutionary advancements in regenerative medicine have brought stem cell therapy to the forefront, offering promising prospects for the regeneration of ischemic cardiac tissue. Yet, its full efficacy, safety, and role in treating ischemic heart disease (IHD) remain limited. This literature review explores the intricate mechanisms underlying stem cell therapy. Furthermore, we unravel the innovative approaches employed to bolster stem cell survival, enhance differentiation, and seamlessly integrate them within the ischemic cardiac tissue microenvironment. Our comprehensive analysis uncovers how stem cells enhance cell survival, promote angiogenesis, and modulate the immune response. Stem cell therapy harnesses a multifaceted mode of action, encompassing paracrine effects and direct cell replacement. As our review progresses, we underscore the imperative for standardized protocols, comprehensive preclinical and clinical studies, and careful regulatory considerations. Lastly, we explore the integration of tissue engineering and genetic modifications, envisioning a future where stem cell therapy reigns supreme in regenerative medicine.

Citing Articles

Advancements in tissue engineering for cardiovascular health: a biomedical engineering perspective.

Razavi Z, Soltani M, Mahmoudvand G, Farokhi S, Karimi-Rouzbahani A, Farasati-Far B Front Bioeng Biotechnol. 2024; 12:1385124.

PMID: 38882638 PMC: 11176440. DOI: 10.3389/fbioe.2024.1385124.

Stem cell therapy as a promising approach for ischemic stroke treatment.

Yaqubi S, Karimian M Curr Res Pharmacol Drug Discov. 2024; 6:100183.

PMID: 38831867 PMC: 11144755. DOI: 10.1016/j.crphar.2024.100183.

Understanding host-graft crosstalk for predicting the outcome of stem cell transplantation.

Labusca L, Zugun-Eloae F World J Stem Cells. 2024; 16(3):232-236.

PMID: 38577233 PMC: 10989282. DOI: 10.4252/wjsc.v16.i3.232.

References

Arjmand B, Abedi M, Arabi M, Alavi-Moghadam S, Rezaei-Tavirani M, Hadavandkhani M . Regenerative Medicine for the Treatment of Ischemic Heart Disease; Status and Future Perspectives. Front Cell Dev Biol. 2021; 9:704903. PMC: 8461329. DOI: 10.3389/fcell.2021.704903. View

van der Spoel T, Jansen Of Lorkeers S, Agostoni P, Van Belle E, Gyongyosi M, Sluijter J . Human relevance of pre-clinical studies in stem cell therapy: systematic review and meta-analysis of large animal models of ischaemic heart disease. Cardiovasc Res. 2011; 91(4):649-58. DOI: 10.1093/cvr/cvr113. View

Menasche P, Vanneaux V, Hagege A, Bel A, Cholley B, Parouchev A . Transplantation of Human Embryonic Stem Cell-Derived Cardiovascular Progenitors for Severe Ischemic Left Ventricular Dysfunction. J Am Coll Cardiol. 2018; 71(4):429-438. DOI: 10.1016/j.jacc.2017.11.047. View

Yu Y, Tham S, Roslan F, Shaharuddin B, Yong Y, Guo Z . Large animal models for cardiac remuscularization studies: A methodological review. Front Cardiovasc Med. 2023; 10:1011880. PMC: 10050756. DOI: 10.3389/fcvm.2023.1011880. View

Bartunek J, Behfar A, Dolatabadi D, Vanderheyden M, Ostojic M, Dens J . Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics. J Am Coll Cardiol. 2013; 61(23):2329-38. DOI: 10.1016/j.jacc.2013.02.071. View

Attar A, Bahmanzadegan Jahromi F, Kavousi S, Monabati A, Kazemi A . Mesenchymal stem cell transplantation after acute myocardial infarction: a meta-analysis of clinical trials. Stem Cell Res Ther. 2021; 12(1):600. PMC: 8650261. DOI: 10.1186/s13287-021-02667-1. View

Ratajczak M, Kucia M, Jadczyk T, Greco N, Wojakowski W, Tendera M . Pivotal role of paracrine effects in stem cell therapies in regenerative medicine: can we translate stem cell-secreted paracrine factors and microvesicles into better therapeutic strategies?. Leukemia. 2011; 26(6):1166-73. DOI: 10.1038/leu.2011.389. View

Volarevic V, Markovic B, Gazdic M, Volarevic A, Jovicic N, Arsenijevic N . Ethical and Safety Issues of Stem Cell-Based Therapy. Int J Med Sci. 2018; 15(1):36-45. PMC: 5765738. DOI: 10.7150/ijms.21666. View

Hastings C, Roche E, Ruiz-Hernandez E, Schenke-Layland K, Walsh C, Duffy G . Drug and cell delivery for cardiac regeneration. Adv Drug Deliv Rev. 2014; 84:85-106. DOI: 10.1016/j.addr.2014.08.006. View

10.

Bock-Marquette I, Saxena A, White M, DiMaio J, Srivastava D . Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature. 2004; 432(7016):466-72. DOI: 10.1038/nature03000. View

11.

Zhang Y, Mignone J, MacLellan W . Cardiac Regeneration and Stem Cells. Physiol Rev. 2015; 95(4):1189-204. PMC: 4600953. DOI: 10.1152/physrev.00021.2014. View

12.

El Khatib M, Ohmine S, Jacobus E, Tonne J, Morsy S, Holditch S . Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration. Stem Cells Transl Med. 2016; 5(5):694-702. PMC: 4835241. DOI: 10.5966/sctm.2015-0017. View

13.

Afjeh-Dana E, Naserzadeh P, Moradi E, Hosseini N, Seifalian A, Ashtari B . Correction to: Stem Cell Differentiation into Cardiomyocytes: Current Methods and Emerging Approaches. Stem Cell Rev Rep. 2022; 18(6):2202. DOI: 10.1007/s12015-022-10395-z. View

14.

Li H, Stoicov C, Rogers A, Houghton J . Stem cells and cancer: evidence for bone marrow stem cells in epithelial cancers. World J Gastroenterol. 2006; 12(3):363-71. PMC: 4066053. DOI: 10.3748/wjg.v12.i3.363. View

15.

Wang W, Chen X, Houser S, Zeng C . Potential of cardiac stem/progenitor cells and induced pluripotent stem cells for cardiac repair in ischaemic heart disease. Clin Sci (Lond). 2013; 125(7):319-27. PMC: 3744218. DOI: 10.1042/CS20130019. View

16.

Abdelwahid E, Kalvelyte A, Stulpinas A, Carvalho K, Guarita-Souza L, Foldes G . Stem cell death and survival in heart regeneration and repair. Apoptosis. 2015; 21(3):252-68. PMC: 5200890. DOI: 10.1007/s10495-015-1203-4. View

17.

Pearl J, Kean L, Davis M, Wu J . Pluripotent stem cells: immune to the immune system?. Sci Transl Med. 2012; 4(164):164ps25. PMC: 3638038. DOI: 10.1126/scitranslmed.3005090. View

18.

Fernandez-Aviles F, Sanz-Ruiz R, Climent A, Badimon L, Bolli R, Charron D . Global Overview of the Transnational Alliance for Regenerative Therapies in Cardiovascular Syndromes (TACTICS) Recommendations: A Comprehensive Series of Challenges and Priorities of Cardiovascular Regenerative Medicine. Circ Res. 2018; 122(2):199-201. DOI: 10.1161/CIRCRESAHA.117.312099. View

19.

Sepantafar M, Maheronnaghsh R, Mohammadi H, Rajabi-Zeleti S, Annabi N, Aghdami N . Stem cells and injectable hydrogels: Synergistic therapeutics in myocardial repair. Biotechnol Adv. 2016; 34(4):362-379. DOI: 10.1016/j.biotechadv.2016.03.003. View

20.

Demkes E, Rijken S, Szymanski M, Hoefer I, Sluijter J, de Jager S . Requirements for Proper Immunosuppressive Regimens to Limit Translational Failure of Cardiac Cell Therapy in Preclinical Large Animal Models. J Cardiovasc Transl Res. 2020; 14(1):88-99. PMC: 7892682. DOI: 10.1007/s12265-020-10035-2. View